At-Home Treatment, Facilities Fees, and Consensus

There’s a tactic agreement that safety and efficacy are not going to be the barrier to rolling out psychedelic medicine— but rather, delivery will prove most challenging.

Who can deliver the treatment, in what environment, and who is going to pay for it?

If drug development is sophisticated gambling, the building of the delivery infrastructure for psyched…

This post is for paying subscribers